Home › Drug Codes › J Codes › J7531 · Prednisolone sodium phosphate
Updated October 1st, 2026

Prednisolone sodium phosphate J Code: J7531

Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
—
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Prednisolone sodium phosphate, orally disintegrating tablet, 1 mg
HCPCS Added Date October 1, 2026
Manufacturer Advanz Pharma (US) Corp.
Route of Administration Oral
Generic Status Single-Source; Branded
Dosage Form Tablet, Orally Disintegrating

About Prednisolone sodium phosphate

Prednisolone Sodium Phosphate is a medication aligned to the HCPCS J Code: J7531 for billing, pricing, and reimbursement purposes in the United States. It is an Immunosuppressant drug administered via the oral route and manufactured by Advanz Pharma (US) Corp.

Manufacturers, reach out to us to add more information.

NDC Code Information

No NDC packages are aligned to J7531 in publicly available CMS files.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
No public NDC alignments
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Prednisolone sodium phosphate Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acquired (autoimmune) hemolytic anemia Acute exacerbations of chronic obstructive pulmonary disease (COPD) Acute exacerbations of multiple sclerosis Acute gouty arthritis Acute leukemia Acute or chronic solid organ rejection Aggressive lymphomas All indicated conditions (pediatric general dosing) Allergic Conditions (atopic dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness) Allergic bronchopulmonary aspergillosis Allergic conditions (atopic dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness) Ankylosing spondylitis Aspiration pneumonitis Asthma Bullous dermatitis herpetiformis Cerebral edema associated with primary or metastatic brain tumor, craniotomy or head injury Congenital adrenal hyperplasia Contact dermatitis Crohn's Disease Crohn's disease Dermatomyositis/polymyositis Diamond-Blackfan anemia Exfoliative erythroderma Fulminating or disseminated pulmonary tuberculosis Hypercalcemia of malignancy Hypersensitivity pneumonitis Idiopathic bronchiolitis obliterans with organizing pneumonia Idiopathic eosinophilic pneumonias Idiopathic pulmonary fibrosis Idiopathic thrombocytopenic purpura Multiple conditions — pediatric general dosing Mycosis fungoides Nephrotic syndrome Nonsuppurative thyroiditis Pemphigus Pneumocystis carinii pneumonia (PCP) associated with hypoxemia in HIV-positive individuals Polymyalgia rheumatica/temporal arteritis Primary or secondary adrenocortical insufficiency Psoriatic arthritis Pure red cell aplasia Relapsing polychondritis Rheumatoid arthritis, including juvenile rheumatoid arthritis Secondary thrombocytopenia Severe erythema multiforme (Stevens-Johnson syndrome) Sjogren's syndrome Sympathetic ophthalmia Symptomatic sarcoidosis Systemic lupus erythematosus Trichinosis with neurologic or myocardial involvement Tuberculous meningitis with subarachnoid block or impending block Ulcerative colitis Uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids Vasculitis
Drug Class
Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Prednisolone sodium phosphate billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for Prednisolone sodium phosphate.
Are there any available Prednisolone sodium phosphate patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for Prednisolone sodium phosphate.
Where can I find Prednisolone sodium phosphate prescribing information?
Our team has not yet identified a source of prescribing information for Prednisolone sodium phosphate.
Where can I find Prednisolone sodium phosphate side effect information?
Our team has not yet identified a source of side effects information for Prednisolone sodium phosphate. Please check back in a few weeks.
Does billing Prednisolone sodium phosphate require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.